Can a simple drug stop Post-Surgery sickness? new study investigates
NCT ID NCT07554040
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether the drug amisulpride can prevent nausea and vomiting after gynecological laparoscopic surgery. About 526 patients will receive the drug after surgery and be monitored for 24 hours to see if they avoid vomiting or needing extra medication. The goal is to find a better way to keep patients comfortable after keyhole surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Amisulpride (also called tropisetron)
What this could lead to
If it works, this could provide a new option to prevent nausea and vomiting after laparoscopic surgery, improving patient comfort and recovery.
What could go wrong
This is an observational study, not a randomized trial, so results may be less conclusive. It only includes gynecological surgeries, so findings may not apply to other types of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PONV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.